Nevro Corp

Company Profile

Nevro Corp had its IPO on 2014-11-06 under the ticker symbol NVRO.

The company operates in the Healthcare sector and Medical Devices industry. Nevro Corp has a staff strength of 1,087 employees.

Stock update

Shares of Nevro Corp opened at $19.91 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $19.56 - $20.3, and closed at $20.28.

This is a +0.6% increase from the previous day's closing price.

A total volume of 444,848 shares were traded at the close of the day’s session.

In the last one week, shares of Nevro Corp have slipped by -0.54%.

Nevro Corp's Key Ratios

Nevro Corp has a market cap of $728.18 million, indicating a price to book ratio of 4.5054 and a price to sales ratio of 3.5244.

In the last 12-months Nevro Corp’s revenue was $419.45 million with a gross profit of $276.37 million and an EBITDA of $-97902000. The EBITDA ratio measures Nevro Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Nevro Corp’s operating margin was -24.85% while its return on assets stood at -11.92% with a return of equity of 0.98%.

In Q2, Nevro Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 4.4%.

Nevro Corp’s PE and PEG Ratio

Forward PE

0

Trailing PE

201.6

PEG

-3.13

Its diluted EPS in the last 12-months stands at $0.1 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of -3.13. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Nevro Corp’s profitability.

Nevro Corp stock is trading at a EV to sales ratio of 3.2262 and a EV to EBITDA ratio of 109.3985. Its price to sales ratio in the trailing 12-months stood at 3.5244.

Nevro Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$569.52 million

Total Liabilities

$77.53 million

Operating Cash Flow

$0

Capital Expenditure

$2.21 million

Dividend Payout Ratio

0%

Nevro Corp ended 2024 with $569.52 million in total assets and $0 in total liabilities. Its intangible assets were valued at $569.52 million while shareholder equity stood at $294.75 million.

Nevro Corp ended 2024 with $0 in deferred long-term liabilities, $77.53 million in other current liabilities, 36000.00 in common stock, $-666950000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $65.19 million and cash and short-term investments were $329.94 million. The company’s total short-term debt was $0 while long-term debt stood at $187.49 million.

Nevro Corp’s total current assets stands at $531.35 million while long-term investments were $0 and short-term investments were $264.76 million. Its net receivables were $69.40 million compared to accounts payable of $30.30 million and inventory worth $120.09 million.

In 2024, Nevro Corp's operating cash flow was $0 while its capital expenditure stood at $2.21 million.

Comparatively, Nevro Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$20.28

52-Week High

$50.54

52-Week Low

$17.88

Analyst Target Price

$28.33

Nevro Corp stock is currently trading at $20.28 per share. It touched a 52-week high of $50.54 and a 52-week low of $50.54. Analysts tracking the stock have a 12-month average target price of $28.33.

Its 50-day moving average was $21.75 and 200-day moving average was $30.73 The short ratio stood at 3.25 indicating a short percent outstanding of 0%.

Around 281.5% of the company’s stock are held by insiders while 10292.9% are held by institutions.